Soluble CD146, a novel endothelial marker, is related to the severity of liver disease

References

• DCines, ESPollak, CABuck, JLoscalzo, GAZimmerman, RPMcEver, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527–61.
   PubMed Web of Science ®Google Scholar
• DVestweber. Molecular mechanisms that control endothelial cell contacts. J Pathol 2000;190:281–91.
   PubMed Web of Science ®Google Scholar
• EDejana, ADel Maschio. Molecular organization and functional regulation of cell to cell junction in endothelium. Thromb Haemost 1995;74:309–12.
   PubMedGoogle Scholar
• NBardin, FAnfosso, JMMassé, ECramer, FSabatier, ALe Bivic, et al. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 2001;98:3677–84.
   PubMed Web of Science ®Google Scholar
• NBardin, VFrancès, GLesaule, NHorschowski, FGeorge, JSampol. Identification of the S-Endo 1 endothelial- associated antigen. Biochem Biophys Res Commun 1996;218:210–16.
   PubMed Web of Science ®Google Scholar
• ANSolovey, LGui, LChang, JEnenstein, PVBrowne, RPHebbel. Identification and functional assessment of endothelial P1H12. J Lab Clin Med 2001;138:322–31.
   PubMedGoogle Scholar
• IMShih. The role of CD146 in biology and pathology. J Pathol 1999;189:4–11.
   PubMed Web of Science ®Google Scholar
• FAnfosso, NBardin, EVivier, FSabatier, JSampol, FDignat-George. Outside-in signaling pathway linked to CD146 engagement in human endothelial cells. J Biol Chem 2001;276:1564–9.
   PubMedGoogle Scholar
• NBardin, VFrancès, VCombes, JSampol, FDignat-George. CD146: biosynthesis and production of a soluble form in human cultured endothelial cells. FEBS Lett 1998;421:12–14.
   PubMedGoogle Scholar
• NBardin, VMoal, FAnfosso, LDaniel, PBrunet, JSampol, et al. Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junction alteration. Thromb Haemost 2003;90:915–20.
   PubMed Web of Science ®Google Scholar
• JMalyszko, JSMalyszko, SBrzosko, SWolczynski, MMysliwiec. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. J Clin Endocrinol Metab 2004;89:4620–7.
   PubMedGoogle Scholar
• OSaito, TSaito, KOkuda, KOkuda, AKotoda, TAkimoto, et al. Serum adiponectin and markers of endothelial injury in hemodialysis patients with arteriosclerosis obliterans. Clin Exp Nephrol 2008;12:58–64.
   PubMedGoogle Scholar
• NBardin, DReumaux, KGeboes, JFColombel, MBlot-Chabaud, JSampol, et al. Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease. Inflamm Bowel Dis 2006;12:16–21.
   PubMedGoogle Scholar
• LCoultas, KChawengsaksophak, JRossant. Endothelial cells and VEGF in vascular development. Nature 2005;438:937–45.
   PubMed Web of Science ®Google Scholar
• PCarmeliet. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389–95.
   PubMed Web of Science ®Google Scholar
• SLFriedman. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 2004;1:98–105.
   PubMedGoogle Scholar
• SLFriedman. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655–69.
   PubMed Web of Science ®Google Scholar
• JMedina, PSanz-Cameno, LGarcía-Buey, SMartín-Vílchez, MLópez-Cabrera, RMoreno-Otero. Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study. J Hepatol 2005;42:124–31.
   PubMedGoogle Scholar
• SJLee, DSemela, JIredale, VHShah. Sinusoidal remodeling and angiogenesis: a new function for the liver specific pericyte? Hepatology 2007;45:817–25.
   PubMed Web of Science ®Google Scholar
• MParola, FMarra, MPinzani. Myofibroblast-like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario. Mol Aspects Med 2008;29:58–66.
   PubMed Web of Science ®Google Scholar
• WSieghart, SFellner, TReiberger, GUlbrich, AFerlitsch, VWacheck, et al. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma. Dig Liver Dis 2009;41:902–6.
   PubMedGoogle Scholar
• SAbdelmoneim, JTalwalkar, SSethi, PKamath, MMFathalla, BRKipp, et al. A prospective pilot study of circulating endothelial cells as a potential new biomarker in portal hypertension. Liver Int 2010;30:191–7.
   PubMedGoogle Scholar
• SKaur, DTripathi, KDongre, VGarg, SRooge, AMukopadhyay, et al. Increased number and function of the endothelial progenitor cells stimulate angiogenesis by resident liver sinusoidal endothelial cells in cirrhosis through paracrine factors. J Hepatol 2012;57:1193–8.
   PubMedGoogle Scholar
• LCastera. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012;142:1293–302.
   PubMed Web of Science ®Google Scholar
• MLupsor Platon, HStefanescu, DFeier, AManiu, RBadea. Performance of unidimensional transient elastography in staging chronic hepatitis C. Results from a cohort of 1,202 biopsied patients from one single center. J Gastrointestin Liver Dis 2013;22:157–66.
   PubMedGoogle Scholar
• PNahon, AKettaneh, ITengher-Barna, MZiol, Vde Lédinghen, CDouvin, et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol 2008;49:1062–8.
   PubMed Web of Science ®Google Scholar
• VWWong, JVergniol, GLWong, JFoucher, HLChan, BLe Bail, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010;51:454–62.
   PubMed Web of Science ®Google Scholar
• CCorpechot, FCarrat, APoujol-Robert, FGaouar, DWendum, OChazouillères, et al. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology 2012;56:198–208.
   PubMed Web of Science ®Google Scholar
• DFigarella-Branger, NSchleinitz, BBoutière-Albanèse, LCamoin, NBardin, SGuis, et al. Platelet-endothelial cell adhesion molecule-1 and CD146:soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies. J Rheumatol 2006;33:1623–30.
   PubMed Web of Science ®Google Scholar
• ASaid, JWilliams, JHolden, PRemington, RGangnon, AMusat, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40:897–903.
   PubMed Web of Science ®Google Scholar
• PKGoon, CJBoos, GYLip. Circulating endothelial cells: markers of vascular dysfunction. Clin Lab 2005;51:531–8.
   PubMed Web of Science ®Google Scholar
• KTaura, SDe Minicis, ESeki, EHatano, KIwaisako, CHOsterreicher, et al. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. Gastroenterology 2008;135:1729–38.
   PubMed Web of Science ®Google Scholar
• DWZhang, YXZhao, DWei, YLLi, YZhang, JWu, et al. HAb18G/CD147 promotes activation of hepatic stellate cells and is a target for antibody therapy of liver fibrosis. J Hepatol 2012;57:1283–91.
   PubMed Web of Science ®Google Scholar
• HGrønbaek, TDSandahl, CMortensen, HVilstrup, HJMøller, SMøller. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis. Aliment Pharmacol Ther 2012;36:173–80.
   PubMed Web of Science ®Google Scholar
• EATsochatzis, KSGurusamy, SNtaoula, ECholongitas, BRDavidson, AKBurroughs. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011;54:650–9.
   PubMed Web of Science ®Google Scholar